Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/1991
06/12/1991EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
06/12/1991EP0431045A1 Retroviral vectors expressing soluble cd4; a gene therapy for aids
06/12/1991EP0430999A1 Monoclonal antibody for inhibiting cell infection by hiv viruses
06/12/1991EP0233908B1 Collagen-specific enzyme with platelet aggregation inhibition properties
06/12/1991CN1052142A Brain derived naurotrophic factor
06/12/1991CN1052141A Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor
06/11/1991US5023322 Analogs of growth hormone releasing factor (GRF) and a method for the preparation thereof
06/11/1991US5023242 Formed with organic acids; antibiotics; antimicrobial bandage, wound dressing
06/11/1991US5023238 By amino-tricyano-propene
06/11/1991US5023237 Methods and compositions for healing ulcers
06/11/1991US5023236 Factor VII/VIIA active site inhibitors
06/11/1991US5023234 Blocking testicular hormone secretions and administering antiandrogen
06/11/1991US5023233 Fibrinogen receptor antagonists
06/11/1991US5023090 Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
06/11/1991US5023085 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
06/11/1991US5023084 Transdermal estrogen/progestin dosage unit, system and process
06/11/1991US5023078 Plasminogen activator-heparin conjugates
06/11/1991CA1284850C Carboxyalkyl peptide derivatives
06/09/1991CA2031755A1 Cyclic renin inhibitors
06/09/1991CA2031735A1 Cyclic renin inhibitors containing 3(s)-amino-4-cyclohexyl-2(r)-hydroxy-butanoic acid or 4-cyclo-hexyl-(2r, 3s)-dihydroxybutanoic acid or related analogs
06/09/1991CA2031684A1 Pharmaceuticals
06/08/1991WO1991009125A1 Proteins and nucleic acids
06/08/1991WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins
06/08/1991WO1991009053A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2069449A1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it and method for treatment of glaucoma
06/08/1991CA2069105A1 Proteins and nucleic acids
06/08/1991CA2031644A1 Peptide antiviral agents
06/06/1991WO1991007978A1 Synthetic calcitonin peptides
06/06/1991DE4014260A1 New hirudin-poly:alkylene glycol conjugate(s) - used as anticoagulants for treatment and prophylaxis of myocardial infarct, arterial occlusion, venous thrombosis and pulmonary embolism
06/06/1991DE3940067A1 New steroidogenesis-induced protein - used to treat conditions requiring stimulation of steroid production, without influencing cAMP cycle
06/06/1991DE3940009A1 New mannose-specific lectin
06/06/1991DE3939801A1 Neue proteine und ihre herstellung New proteins and their production
06/06/1991DE3939797A1 Neue vom neuropeptid y abgeleitete peptide New-derived neuropeptide y peptide
06/06/1991CA2069943A1 Synthetic calcitonin peptides
06/05/1991WO1991008313A1 Antisense oligonucleotide inhibition of papillomavirus
06/05/1991WO1991007986A1 Method of treating septic shock
06/05/1991EP0430930A1 Factor IX protein
06/05/1991EP0430645A2 Vaccines
06/05/1991EP0430637A1 Fibrinolytic protein and production method thereof
06/05/1991EP0430538A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1
06/05/1991EP0430200A1 Drug for s.c. or i.m. application containing polypeptides
06/05/1991EP0430193A1 Monoclonal antibodies and their use
06/05/1991EP0430121A1 Process for the purification of lipocortines
06/05/1991EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity
06/05/1991EP0429663A1 Human prourokinase-like polypeptides and their preparation methods
06/05/1991EP0429628A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi
06/05/1991EP0429570A1 Osteoinductive compositions
06/05/1991EP0429544A1 Synthetic, anti-complement protein and the gene encoding same
06/05/1991EP0429537A1 Atrial natriuretic peptide clearance inhibitors
06/05/1991EP0429502A1 O-glycosylated igf-1
06/05/1991EP0429484A1 Porcine polyclonal and monoclonal antibodies
06/05/1991EP0429454A1 Improvements relating to the control of neoplastic tissue growth
06/05/1991CN1051937A Stem cell factor
06/05/1991CN1051936A Drythropoietin isoforms
06/05/1991CN1051934A Process for preparation of genelic vectors for nerve growth factor expression in eukaryotic cells
06/05/1991CN1051914A Peptides
06/05/1991CA2070424A1 Method of treating septic shock
06/04/1991US5021554 Process for protein particle size reduction using a fluid-energy mill
06/04/1991US5021551 Method of enhancing peptide immunogenicity
06/04/1991US5021549 Physiologically active substances, probestin and prostatin and production thereof
06/04/1991US5021439 Senile dementia and memory dysfunction
06/04/1991US5021403 Antibiotic agents
06/04/1991US5021349 Culture medium containing human albumin, process for the preparation of an injectable product from this medium, product obtained and its use, and composition obtained
06/04/1991US5021341 Antibiotic agent produced by the cultivation of Zalerion microorganism in the presence of mannitol
06/04/1991US5021243 Process for the preparation of factor VIII:C-deficient plasma, and a deficient plasma obtained in this way
06/04/1991US5021241 Long-term sustained-release preparation
06/04/1991US5021239 Use of M-CSF to improve lipoprotein cholesterol profiles
06/04/1991US5021234 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense
06/02/1991WO1991008301A1 PROTEINS PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS
06/02/1991WO1991008233A1 New blood-clot-dissolving proteins, and their preparation from the leech hirudo medicinalis
06/02/1991WO1991007984A1 Treatment of atopic disorders with gamma-interferon
06/02/1991WO1991007977A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991WO1991007976A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2070166A1 Proteins inhibiting the interaction between an immunoglobin fc fragment and its receptor, and their therapeutical use, especially in the treatment of hiv related ailments
06/02/1991CA2069902A1 Peptides and antibodies that inhibit integrin-ligand binding
06/02/1991CA2069754A1 Anti-thrombotic peptides and pseudopeptides
06/02/1991CA2065258A1 Blood-clot-dissolving proteins, and their preparation from the leech hirudo medicinalis
06/02/1991CA2031233A1 Megakaryocyte production
05/1991
05/31/1991CA2030293A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1
05/30/1991WO1991007509A1 Localization and characterization of the wilms's tumor gene
05/30/1991WO1991007499A1 The scl gene, and the encoded hematopoietic factor
05/30/1991WO1991007495A1 A mammalian cytokine, il-11
05/30/1991WO1991007491A1 Non-glycosylated fgf-4 and compositions containing the same
05/30/1991WO1991007484A1 Protein having activity like that of human protein c and/or activated human protein c
05/30/1991WO1991007439A1 Control of secretion of milk
05/30/1991WO1991007437A2 Improved cd-30 antibodies and fragments thereof
05/30/1991WO1991007435A1 Purified protein and bioactive pharmaceutical
05/30/1991WO1991007432A1 Antihemostatic factor vii peptides
05/30/1991WO1991007430A1 Peptides containing cyclic tripeptides
05/30/1991WO1991007429A1 Anti-aggregatory peptides containing a mercaptan or sulfide moiety
05/30/1991WO1991007190A1 Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute
05/30/1991WO1991007189A1 Conglutinin fragments, their production and use
05/30/1991WO1991007185A1 Inhibition of malignant cells having gm1 ganglioside sites by administration of cholera toxin
05/30/1991WO1991007166A1 Compositions and methods for reducing the risk of sunlight and ultraviolet induced skin cancer
05/30/1991WO1991005555A3 N-acyl peptide metalloendopeptidase inhibitors and methods of using same
05/30/1991CA2068533A1 Control of secretion of milk
05/30/1991CA2030947A1 Process for the production of unfused protein in e. coli
05/30/1991CA2030943A1 Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
05/29/1991WO1991007985A1 Monoclonal antibody which distinguishes helper inducer and supressor inducer ce4+ lymphocytes
05/29/1991EP0429438A2 Bone repair using collagen
1 ... 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 3027 ... 3163